<DOC>
	<DOC>NCT02312362</DOC>
	<brief_summary>Objective: To compare intraocular pressure lowering effect of combined sclerotomy ab interno with phacoemulsification and phacoemulsification alone, in primary or secondary open angle glaucoma patients. Study design: Prospective, randomized, case- control interventional surgical trial</brief_summary>
	<brief_title>High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<criteria>Patients suffering from primary openangle glaucoma (POAG) inadequately controlled with maximum tolerated medical therapy and who will be treated with cataract surgery. One eyed patients Unwilling or unable to give consent, unwilling to accept randomization, or unable to return for scheduled protocol visits The presence of extreme narrow angle with complete or partial closure in either eye, except for occludable angles treated with a patent iridectomy Any abnormality preventing reliable applanation tonometry, any opacity or patient uncooperativeness that would restrict adequate examination of the ocular fundus or anterior chamber of either eye The risk of visual field or visual acuity worsening as a consequence of participation in the trial, in the investigator's opinion Any clinically significant, serious, or severe medical or psychiatric condition; any condition that, in the investigator's opinion, would interfere with optimal participation in the study or present a special risk to the patient Participation in any other investigational study within 30 days prior to baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>HFDS</keyword>
	<keyword>ab interno</keyword>
	<keyword>MIGS</keyword>
	<keyword>surgery</keyword>
</DOC>